FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Revance Therapeutics, Inc.: accounts_payable

One fact, its scope and the complete path back to the official record.

Period: as of 2023-06-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/f4767602-17d6-42e6-a095-24351aece735

Reported value

$8.345M{"amount": 8345000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"}
Entity
Revance Therapeutics, Inc.
Metric
accounts_payable
Period
as of 2023-06-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001479290-23-000093 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:41:26.423200+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001479290/accounts-payable/2023-06-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.